Oncodesign Precision Medicine SA (ALOPM)
EU
The current ALOPM market cap is 14.01M. The company's latest EPS is EUR -0.4448 and P/E is -1.73.
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
EUR (€) | EUR (€) | |
Total Revenue | 8.27M | 1.08M |
Operating Income | -1.61M | -9.94M |
Net Income | -231k | -8.09M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
EUR (€) | EUR (€) | |
Total Assets | 18.37M | 16.63M |
Total Liabilities | 8.53M | 14.88M |
Total Equity | 9.84M | 1.75M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
EUR (€) | EUR (€) | |
Operating | N/A | N/A |
Investing | N/A | N/A |
Financing | N/A | N/A |
Market Cap | 14.01M |
Price to Earnings Ratio | -1.73 |
Price to Sales Ratio | 12.98 |
Price to Cash Ratio | 43.5 |
Price to Book Ratio | 8 |
Dividend Yield | - |
Shares Outstanding | 18.19M |
Average Volume (1 week) | 33.14k |
Average Volume (1 Month) | 11.49k |
52 Week Change | -57.46% |
52 Week High | 2.06 |
52 Week Low | 0.73 |
Spread (Intraday) | 0.01 (1.04%) |
Company Name | Oncodesign Precision Medicine SA |
Address |
18 rue jean mazen dijon, cote-d'or 21000 |
Website | https://www.oncodesign.com |
Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.